Search Results 1-10 of 27718 for intestinal metaplasia

  1. Gastrointestinal Neoplasia Clinic - Overview

    Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

  2. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

    That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

  3. Barrett's esophagus - Symptoms and causes - Mayo Clinic

    Frequent heartburn and regurgitation of stomach contents; Difficulty swallowing food; Less commonly, chest pain. Curiously, approximately half of the people ...

  4. Stomach cancer - Symptoms and causes - Mayo Clinic

    Stomach cancer, which is also called gastric cancer, is cancer that begins in the stomach. Learn about symptoms, causes, detection and treatments.

  5. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  6. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

    ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

  7. Optimizing surveillance in patients with dysplastic Barrett esophagus after endoscopic eradication - Mayo Clinic

    Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.

  8. Screening strategies for prevalent esophageal adenocarcinoma may be different from those recommended for Barrett's esophagus - Mayo Clinic

    "Our results suggest the existence of an alternative pathway — one in which metaplasia progresses rapidly to EAC , with or without intestinal metaplasia," says ...

  9. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  10. Assessing the prevalence of Barrett's esophagus in patients with scleroderma - Mayo Clinic

    ... intestinal metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies ...